Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ADG106 |
Trade Name | |
Synonyms | ADG-106|ADG 106 |
Drug Descriptions |
ADG106 is a monoclonal antibody targeting CD137, which potentially enhances antitumor immune response (J Clin Oncol 42, 2024 (suppl 16); e14507). |
DrugClasses | TNFRSF9 Antibody 32 |
CAS Registry Number | NA |
NCIT ID | C160715 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ADG106 | ADG106 | 0 | 1 |
ADG106 + ADG116 | ADG106 ADG116 | 0 | 1 |
ADG106 + ADG126 | ADG106 ADG126 | 0 | 1 |